Umbralisib and Pembrolizumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Clinical trial NCT03776864 · TERMINATED
Trial details
- NCT number
- NCT03776864
- Sponsor
- University of Washington
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2021-09-14
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.